Abstract
In the treatment of 32 cases of bronchial asthma by injection of BCG polysaccharide nucleic acid (PSN) into Zusanli (ST 36), Dingchuan (Ex-B 1) and Feishu (BL 13) in summer, the total effective rate reached 84.4%, with T cell subgroup determined before and after the treatments at the same time. In summer, injection of PSN can enhance CD8+ (P<0.02) for the patients in lower level, and reduce the enlarged ratio of CD4+/CD8+ (P<0.01), indicating this method can regulate the immune functions and provides a convenient and effective method to the treatment of bronchial asthma.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
